|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Operating expenses: | |||
| Cost of revenue, exclusive of depreciation and amortization | |||
| Technology and development | |||
| Sales and marketing | |||
| General and administrative | |||
| Depreciation and amortization | |||
| Impairment of goodwill | |||
| Total operating expenses | |||
| Operating loss | |||
| Other income (expense): | |||
| Changes in fair value of financial instruments carried at fair value, net | |||
| Interest expense | |||
| Gain (loss) on extinguishment of debt | |||
| Other income (expense), net | |||
| Total other income (expense), net | |||
| Loss before income taxes | |||
| Income tax benefit | |||
| Net loss | |||
| Net loss per share applicable to common shareholders, basic | |||
| Net loss per share applicable to common shareholders, diluted | |||
| Weighted-average number of common shares used in net loss per share applicable to common shareholders, basic | |||
| Weighted-average number of common shares used in net loss per share applicable to common shareholders, diluted |
Loading...
